Published in N Engl J Med on May 26, 1983
Genital human papillomavirus infection. Proc Natl Acad Sci U S A (1994) 2.12
Human papillomaviruses: are we ready to type? Clin Microbiol Rev (1989) 1.37
Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regression. Virology (2011) 1.30
The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells. J Virol (1996) 1.29
Latent infection induced with cottontail rabbit papillomavirus. A model for human papillomavirus latency. Am J Pathol (1994) 1.03
The biology of papillomavirus latency. Open Virol J (2012) 1.03
Transcriptional regulatory elements in the noncoding region of human papillomavirus type 6. J Virol (1988) 0.99
Occurrence of HPV genomes in penile smears of healthy men. Arch Dermatol Res (1987) 0.91
Tissue site-specific enhancer function of the upstream regulatory region of human papillomavirus type 11 in cultured keratinocytes. J Virol (1989) 0.90
Altered expression of TAP-1 and major histocompatibility complex class I in laryngeal papillomatosis: correlation of TAP-1 with disease. Clin Diagn Lab Immunol (2000) 0.87
Changes in HPV infection in patients with anogenital warts and their partners. Genitourin Med (1993) 0.79
Pathobiology of papillomavirus-related cervical diseases: prospects for immunodiagnosis. Clin Microbiol Rev (1991) 0.77
Diagnostic and therapeutic pitfalls in benign vocal fold diseases. GMS Curr Top Otorhinolaryngol Head Neck Surg (2013) 0.75
Human papilloma virus infections. Can Fam Physician (1989) 0.75
Treatment of respiratory papillomatosis with adenine arabinoside. Arch Dis Child (1985) 0.75
Mutants of SV40 with an altered small t protein are reduced in their ability to transform cells. Cell (1978) 5.23
Normal rat cell lines deficient in nuclear thymidine kinase. Virology (1981) 4.13
Differential expression of tropomyosin forms in the microfilaments isolated from normal and transformed rat cultured cells. J Biol Chem (1983) 1.99
Transformation of rat embryo fibroblasts by cloned polyoma virus DNA fragments containing only part of the early region. Proc Natl Acad Sci U S A (1980) 1.89
Conserved sequences at the origin of adenovirus DNA replication. J Virol (1982) 1.83
Simian virus 40 small-t protein is required for loss of actin cable networks in rat cells. J Virol (1980) 1.68
Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg (1989) 1.47
Requirement for the large T and small T proteins of SV40 in the maintenance of the transformed state. Cold Spring Harb Symp Quant Biol (1980) 1.43
Retransformation of a simian virus 40 revertant cell line, which is resistant to viral and DNA infections, by microinjection of viral DNA. J Virol (1979) 1.41
Minimally invasive aortic valve replacement: echocardiographic and clinical results. Am Heart J (2001) 1.39
Establishment and transformation diminish the ability of fibroblasts to contract a native collagen gel. J Cell Biol (1980) 1.32
Acute epiglottitis in adults. Laryngoscope (1971) 1.32
Elevation of the epidermal growth factor receptor and dependent signaling in human papillomavirus-infected laryngeal papillomas. Cancer Res (1999) 1.21
Replication of plasmid-derived human papillomavirus type 11 DNA in cultured keratinocytes. J Virol (1992) 1.21
The anesthetic management of the patient with an anterior mediastinal mass. Anesthesiology (1984) 1.20
Laryngeal papillomatosis: clinical, histopathologic and molecular studies. Laryngoscope (1987) 1.18
Variable defectiveness for lytic growth of the dl 54/59 mutants of simian virus 40. J Virol (1980) 1.15
Transformation by adenovirus early region 2A temperature-sensitive mutants and their revertants. Virology (1981) 1.13
Verrucous carcinoma of the larynx. Possible human papillomavirus etiology. Arch Otolaryngol (1985) 1.13
Simian virus 40 induces the production of a polypeptide transforming factor(s). Virology (1981) 1.12
Recurrent respiratory papillomatosis: altered CD8(+) T-cell subsets and T(H)1/T(H)2 cytokine imbalance. Clin Immunol (1999) 1.10
Human papillomavirus type 6a DNA in the lung carcinoma of a patient with recurrent laryngeal papillomatosis is characterized by a partial duplication. J Gen Virol (1992) 1.06
Anchorage independence: analysis of factors affecting the growth and colony formation of wild-type and dl 54/59 mutant SV40-transformed lines. Virology (1979) 1.04
Efficacy of DHE photodynamic therapy for respiratory papillomatosis: immediate and long-term results. Laryngoscope (1998) 1.04
Latent infection induced with cottontail rabbit papillomavirus. A model for human papillomavirus latency. Am J Pathol (1994) 1.03
SV40 mutants with an altered small-t protein are tumorigenic in newborn hamsters. Virology (1981) 1.02
Human papillomavirus type 11 transcripts are present at low abundance in latently infected respiratory tissues. Virology (1995) 1.02
Radionuclide lung scanning in the diagnosis of endobronchial foreign bodies in children. J Pediatr (1973) 1.00
A destructive maxillary cemento-ossifying fibroma following maxillofacial trauma. Laryngoscope (1984) 1.00
Minimally invasive versus sternotomy approaches for mitral reconstruction: comparison of intermediate-term results. J Thorac Cardiovasc Surg (2001) 0.99
The use of the tidal breathing flow volume loop in laryngotracheal disease of neonates and infants. Laryngoscope (1982) 0.97
Laryngeal papilloma cells have high levels of epidermal growth factor receptor and respond to epidermal growth factor by a decrease in epithelial differentiation. Cancer Res (1993) 0.97
Culture of human laryngeal papilloma cells in vitro. Otolaryngol Head Neck Surg (2000) 0.97
Differential regulation of human papillomavirus type 6 and 11 early promoters in cultured cells derived from laryngeal papillomas. J Virol (1995) 0.96
Photodynamic therapy using m-tetra(hydroxyphenyl) chlorin. An animal model. Arch Otolaryngol Head Neck Surg (1994) 0.96
Is papillomavirus detectable in the plume of laser-treated laryngeal papilloma? Arch Otolaryngol Head Neck Surg (1990) 0.95
Presence of human papillomavirus type 16 related sequences in verrucous carcinoma of the larynx. Cancer Res (1986) 0.95
Corrosive injury of the esophagus. Result of ingesting some denture cleanser tablets and powder. Arch Otolaryngol (1978) 0.94
Transformation of rat cells by the hybrid virus Ad2(2+) HEY. J Gen Virol (1979) 0.93
Induction of E6/E7 expression in cottontail rabbit papillomavirus latency following UV activation. Virology (1999) 0.92
Upper digestive tract burns caused by Denalan denture cleanser powder. Ann Otol Rhinol Laryngol (1975) 0.92
Salivary gland scinti-scanning with technetium 99m pertechnetate. Laryngoscope (1969) 0.92
Enriched HLA-DQ3 phenotype and decreased class I major histocompatibility complex antigen expression in recurrent respiratory papillomatosis. Clin Diagn Lab Immunol (1994) 0.91
Abnormal differentiation of human papillomavirus-induced laryngeal papillomas. Arch Otolaryngol Head Neck Surg (1990) 0.90
Congenital laryngeal saccular cyst of the newborn. Laryngoscope (1984) 0.89
The small-t protein of SV40 is required for loss of actin cable networks and plasminogen activator synthesis in transformed rat cells. Virology (1980) 0.89
Robotic-assisted instruments enhance minimally invasive mitral valve surgery. Ann Thorac Surg (2000) 0.89
Overexpression of PTEN/MMAC1 and decreased activation of Akt in human papillomavirus-infected laryngeal papillomas. Cancer Res (2000) 0.89
Persistence and expression of human papillomavirus during interferon therapy. Arch Otolaryngol Head Neck Surg (1988) 0.89
Port-access minimally invasive CABG: techniques and results. J Card Surg (2001) 0.88
Ultrasonics in otolaryngology. An aid in the diagnosis of middle ear fluid. Arch Otolaryngol (1972) 0.88
Bilateral vocal cord paralysis following endotracheal intubation. Arch Otolaryngol Head Neck Surg (1986) 0.88
A comparison of radiation-induced and presbylaryngeal dysphonia. Otolaryngol Head Neck Surg (2001) 0.88
Altered expression of TAP-1 and major histocompatibility complex class I in laryngeal papillomatosis: correlation of TAP-1 with disease. Clin Diagn Lab Immunol (2000) 0.87
Cystic fibrosis and hearing loss. Arch Otolaryngol (1979) 0.87
Clinical effects of photodynamic therapy on recurrent laryngeal papillomas. Arch Otolaryngol Head Neck Surg (1992) 0.87
Globe ptosis secondary to maxillary sinus mucocele. Ophthal Plast Reconstr Surg (1995) 0.86
Frontal sinusitis and its intracranial complications. Int J Pediatr Otorhinolaryngol (1983) 0.86
Interaction of human papillomavirus type 11 E7 protein with TAP-1 results in the reduction of ATP-dependent peptide transport. Clin Immunol (2001) 0.86
Retinoic acid regulates, in vitro, the two normal pathways of differentiation of human laryngeal keratinocytes. In Vitro Cell Dev Biol (1991) 0.86
Tumorigenicity of SV40-transformed human and monkey cells in immunodeficient mice. Virology (1983) 0.86
High-speed drill noise and hearing: audiometric survey of 70 dentists. J Am Dent Assoc (1978) 0.86
Distant metastases from carcinoma of the larynx. Laryngoscope (1971) 0.85
Laryngeal papillomas. Clin Dermatol (1989) 0.85
Vocal cord polyps: biochemical and histologic evaluation. Laryngoscope (1985) 0.84
Tumorigenicity of revertant from an SV40-transformed line. J Supramol Struct (1979) 0.84
Impact of heparin bonding on pediatric cardiopulmonary bypass: a prospective randomized study. Ann Thorac Surg (2000) 0.84
Hematoporphyrin derivative therapy of papillomas. Experimental study. Arch Otolaryngol Head Neck Surg (1986) 0.84
A key DNA-protein interaction determines the function of the 5'URR enhancer in human papillomavirus type 11. Virology (1991) 0.84
Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VII. Induction of SV40 TrAg in nonpermissive mouse cells by early viable SV40 deletion (o.54/0.59) mutants. Virology (1980) 0.84
Closure of tracheocutaneous fistula using a modified cutaneous Z-plasty. Am J Otolaryngol (1993) 0.83
Replication and persistence of HPV DNA in cultured cells derived from laryngeal papillomas. Virology (1992) 0.83
Case report of robotic instrument-enhanced mitral valve surgery. J Thorac Cardiovasc Surg (2000) 0.83
Voice restoration after laryngopharyngoesophagectomy. Otolaryngol Head Neck Surg (1989) 0.83
Efficacy of intravenous delta-aminolaevulinic acid photodynamic therapy on rabbit papillomas. Br J Cancer (1995) 0.82
N-myc oncogene expression in porcine renal development and oncogenesis. Pediatr Res (1991) 0.81
Innominate artery compression of the trachea. Bull N Y Acad Med (1984) 0.81
Severe calcification does not affect long-term outcome of mitral valve repair. Ann Thorac Surg (1994) 0.81
Tracheal bronchogenic cyst: a new clinical entity? Ann Otol Rhinol Laryngol (1987) 0.81
Identification of DNA-protein interactions and enhancer activity at the 5' end of the upstream regulatory region in human papillomavirus type 11. Virology (1989) 0.81
Mechanical endothelial damage results in basic fibroblast growth factor-mediated activation of extracellular signal-regulated kinases. Surgery (1999) 0.80
Sjögren's syndrome. Additional diagnostic tools. Arch Otolaryngol (1968) 0.80
Bacteriophage P22 lysogenises efficiently at high multiplicities of infection because Salmonella typhimurium DNA synthetic capacity is limited. Nature (1976) 0.80
Microbiology of the canine nasal cavities. Rhinology (1980) 0.80
Benign adenoma of the middle ear cavity causing facial paralysis. Otolaryngol Head Neck Surg (1981) 0.80
Molecular heterogeneity of female genital wart (condylomata acuminata) papilloma viruses. Int J Gynecol Pathol (1984) 0.80
Dihematoporphyrin ether-induced photosensitivity in laryngeal papilloma patients. Lasers Surg Med (1990) 0.79
Pleomorphic adenoma of the nasal septum. Otolaryngol Head Neck Surg (1985) 0.78